Framework of the proposed level-based competitive swarm optimization. by Ke Lu (124270)

Subjects:

Comparison results of the compared algorithms on CEC’2013 functions with 6 × 105 fitness evaluations. by Ke Lu (124270)

Subjects:

Summary of the 28 CEC’13 test functions. by Ke Lu (124270)

Subjects:

Parameters applied in sensors distribution by LCSO. by Ke Lu (124270)

Subjects:

Image2_Case report: Double filtration plasmapheresis (DFPP) for severe rhesus-D alloimmunization in two pregnant patients.tiff by Yuling Liang (4636447)

“…The favorable results of the two patients indicate that DFPP may be an effective and safe treatment modality for RhD immunity in pregnant women. …”

image_2_Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis.jpeg by Gabriel Mizraji (5139530)

“…Investigations of the immune mechanism of RvD2 actions reveal that 6 weeks after infection, the gingiva of RvD2-treated mice exhibit decreased CD4⁺ T-cells as well as lower RANKL expression levels and higher osteoprotegerin expression levels. …”

Time course of the variances (<i>V</i>_<i>ip</i>, <i>V</i>_<i>g</i>) after switching interaction strength. by Naoto Nishiura (11668953)

“…The two variances of the non-target output genes decrease, while <i>V</i>_<i>g</i> < <i>V</i>_<i>ip</i> is maintained throughout the evolutionary course (a). …”

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques by Vincent Munster (9399053)

“…Here, we studied the pathogenicity of variants of concern (VOC) B.1.1.7 and B.1.351 in rhesus macaques and compared it to a recent clade B.1 SARS-CoV-2 isolate containing the D614G substitution in spike. …”

Changes in tumor hypoxia for the simulated PolyhHb enhanced infusion model. by Donald A. Belcher (4836420)

CD74-ICD binds the IL-1β promotor in DC, promoting their tolerogenic phenotype. by Bianca Pellegrino (20314999)

<i>OsNF-YAs</i> RNAi mutants are more resistant to viruses. by Xiaoxiang Tan (12542842)

Amino acid substitutions within SARS-CoV-2 Spike RBD may have contributed to zoonotic emergence. by Carina Conceicao (9904159)

“…The cell–cell fusion activity of individual point mutants, as well as a full chimaera containing all 8 mutations (chimaera), was then examined using human ACE2 expressing target cells with activity normalised to the fusion seen with the wildtype (WT) viral glycoprotein of (C) SARS-CoV-2 or (D) RaTG13. …”

Image_5_Host autophagy limits Toxoplasma gondii proliferation in the absence of IFN-γ by affecting the hijack of Rab11A-positive vesicles.TIF by Lingtao Pan (9433257)

“…Further, after T. gondii infection, the abundance of Rab11A remained stable in wild-type HeLa cells but decreased in atg5^−/− mutant. …”

Data Sheet 5_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.zip by Haiyan Liao (6100043)

Changes in <i>OEF</i> for the simulated PolyhHb enhanced infusion model. by Donald A. Belcher (4836420)

Spike IgG decay profile of high plasmapheresis donors. by Fiona Tea (2502700)

A Fractional Bond Order of 1/2 in Pd₂⁵⁺−Formamidinate Species; The Value of Very High-Field EPR Spectra by John F. Berry (1391989)

“…Reaction of Pd₂(DAniF)₄, <b>1</b>, (DAniF = di-<i>p</i>-anisylformamidinate) with 1 equiv of AgPF₆ in CH₂Cl₂ at or below −10 °C produces the paramagnetic species [Pd₂(DAniF)₄]PF₆, <b>1-PF</b><b>₆</b>, that has been studied by X-ray crystallography, UV−vis spectroscopy, electrochemistry, and multifrequency (9.5, 34.5, 110, and 220 GHz) EPR spectroscopy. Upon oxidation of the precursor, the Pd−Pd distance decreases by 0.052 Å from 2.6486(8) to 2.597(1) Å. …”

Proteins identified by 2D-DIGE LC-MS/MS with differential abundance in CDR 1 vs. CDR 0 CSF. by Richard J. Perrin (224124)

“…</p><p>Column 4, name of protein identified by MASCOT.</p><p>Column 5, fold-change in protein abundance; negative values indicate decreases in CDR 1 vs. …”

Data_Sheet_1_Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models.docx by Aleksandar Janev (11024772)

“…This study aimed to investigate the anticancer activity of hAM homogenate on 2D and 3D cancer models. We evaluated the effects of hAM homogenates on the human muscle invasive bladder cancer urothelial (T24) cells, papillary cancer urothelial (RT4) cells and normal porcine urothelial (NPU) cells as well as on human mammary gland non-tumorigenic (MCF10a) cells and low-metastatic breast cancer (MCF7) cells. …”